Oaktree Acquisition Corp. III Life Sciences (OACCU) Total Current Liabilities (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Total Current Liabilities came in at $1.6 million in Q1 2026, up 53.44% YoY from $1.1 million in Q1 2025, and up 24.97% on a QoQ basis from $1.3 million in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Total Current Liabilities (2024 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 3 years of Total Current Liabilities data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Total Current Liabilities rose 53.44% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 53.44% YoY) and the FY2025 annual result came in at $1.3 million, up 78.69% from the prior year.
- Total Current Liabilities improved to $1.6 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.6 million in Q1 2026 to a low of $727323.0 in Q4 2024.
- A 3-year average of $1.2 million and a median of $1.2 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2025 — Total Current Liabilities soared 78.69% — and 2026, when it surged 53.44%.
- Tracing OACCU's Total Current Liabilities over 3 years: stood at $727323.0 in 2024, then surged by 78.69% to $1.3 million in 2025, then advanced by 24.97% to $1.6 million in 2026.
- The last three Total Current Liabilities figures came in at $1.6 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 727,323.00 |